|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 欧洲新生儿呼吸窘迫综合征防治指南-2010版显示文摘呼吸窘迫综合征(RDS)是由于肺表面活性物质(PS)缺乏及肺结构发育不成熟所致,多见于早产儿,自然病程为生后当时或很快发病,并在生后2d内进行性恶化,如不及时治疗,因进行性缺氧和呼吸衰竭而死亡,存活者,在生后2—4d病情开始改善。胎龄越小,RDS发生率越高,2006年EuroNeoStat的数据显示:胎龄23~25周的早产儿RDS发生率为91%, | Sweet DG Carnielli V Greisen G Hallman M Ozek E Plavka R Saugstad OD Simeoni U Speer CP Halliday HL 袁琳(翻译) 陈超(审校) | 2011 | 中华儿科杂志2011，49，1： | 137 |
| 2 | 欧洲早产儿呼吸窘迫综合征防治共识指南(2013版)显示文摘本次指南更新包括了自2010年以来Cochrane系统评价和医学文献中的最新证据,并采纳了一种新的证据评估分级系统(GRADE)。以往关于早期肺表面活性物质和持续气道正压通气治疗的推荐目前拥有了更坚定的循证依据。对产房复苏、稳定生命体征等内容进行了较大扩充。生命体征稳定后的氧疗目前仍存在一定的争议,但是在获得更多的证据之前,血氧饱和度的目标范围不应低于90%,支持治疗对于超早早产儿仍然极为重要。指南对其他注意事项进行了缩减。 | Sweet D Carnielli V Greisen G Hallman M Ozek E Plavka R Saugstad OD Simeoni U Speer CP Halliday HL 王敏婕 袁琳 陈超 | 2014 | 中华儿科杂志2014，52，10： | 34 |
| 3 | Management of bronchopulmonary dysplasia in infants:guidelines for corticosteroid use显示文摘 | Grier DG Halliday HL | 2005 | Drugs2005，65，1： | 1 |
| 4 | Inhaled versus systemic cor-ticosteroid for the treatment of chronic lung disease in ventilated very low birth weight preterm infants 显示文摘 | Shah SS Ohlsson A Halliday HL | 2012 | Cochrane Database Syst Rev2012，5，00： | 1 |
| 5 | Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants显示文摘 | McCall EM Alderdice F Halliday HL | 2010 | Cochrane Database Syst Rev2010，17，00： | 1 |
| 6 | Surfactants : past, present and future 显示文摘 | Halliday HL | 2008 | J Pefinatol2008，281，： | 1 |
| 7 | Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates显示文摘 | Shah VS Ohlsson A Halliday HL | 2012 | Cochrane Database Syst Rev2012，5，00： | 1 |
| 8 | Corticosteroids in the prevention and management of bronchopulmonary dysplasia显示文摘 | Grier DG Halliday HL | 2003 | Semi Neonatol2003，8，1： | 1 |
| 9 | Corticosteroids in the prevention and management of bronchopulmonary displasia 显示文摘 | Grier DG Halliday HL | 2003 | Semin Neonatol2003，8，1： | 1 |
| 10 | Early(< 8 days)postnatal corticosteroids for preventing chronic lung disease in preterm infants显示文摘 | Halliday HL Ehrenkranz RA Doyle LW | 2010 | Cochrane Database Syst Rev2010，，00： | 1 |
| 11 | Muhicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome 显示文摘 | Halliday HL Tarnow-Mordi WO Coreoran JD | 1993 | Arch Dis Child1993，，： | 1 |
| 12 | Neonatal management and long-term sequelae显示文摘 | Halliday HL | 2009 | Besl Pract Res Clin Obstet Gynaecol2009，23，6： | 1 |
| 13 | Early(<8days) postnatal corticosteroids for preventing chronic lung disease in preterm infants显示文摘 | Halliday HL Ehrenkranz RA Doyle LW | 2009 | Cochrane Database Syst Rev2009，21，00： | 1 |
| 14 | Extremely low-dose dex- amethasone to facilitate extubation in mechanically ventilated preterm babies 显示文摘 | Tanney K Davis J Halliday HL | 2011 | Neonatology2011，100，3： | 1 |
| 15 | Inhaled versus systemic cor- ticosteroid for preventing chronic lung disease in ventilated very low birth weight preterm neonates显示文摘 | Shah SS Ohlsson A Halliday HL | 2012 | Cochrane Database Syst Rev2012，5，00： | 1 |
| 16 | Delayed(>3weeks)postnatal corticosteroids for chronic lung disease in preterm infants显示文摘 | Halliday HL Ehrenkranz RA Doyle LW | 2003 | Cochrane Database Syst Rev2003，，00： | 1 |
| 17 | Treatment of Severe meconiun aspiration syndrome with porcine surfactant Collaborative Surfactant Study Group显示文摘 | Halliday HL speer Cp Robertson B | | 0，，12： | 1 |
| 18 | Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants显示文摘 | Halliday HL Ehrenkranz RA Doyle LW | 2003 | Cochrane Database Syst Rev2003，，00： | 1 |
| 19 | History of surfactant from 1980 显示文摘 | Halliday HL | 2005 | Biol Neonate2005，87，4： | 1 |
| 20 | Early (《96 hours) postnatal corticosteroids for preventing chronic lung disease in preterm infants显示文摘 | Halliday HL Ehrenkranz RA Doyle LW | 2003 | Cochrane Database Syst Rev2003，，00： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员